Protective and therapeutic effects of statin treatment in neurodegenerative diseases have been reported by several studies.[18, 19, 20] Particularly the use of simvastatin has been correlated with a suppression of proinflammatory molecules and microglial activation, inhibition of oxidative stress and attenuation of alpha‐synuclein aggregation.[19] Important clinical evidence for therapeutic potential of statins was described by Wahner et al. Here, SNCA is linked to neurodegenerative disease.